new indications for glp 1 drugs GLP-1 Medications Infographic GI Adverse Effects of Glucagon-Like
Description
2241935) Next review due on Jan 02, 2029
For this reason, people seek alternate management methods, such as medication or treatments
The list includes medications with unique pharmacokinetic properties, such as: Clinically, these drugs are primarily prescribed for the treatment of type 2 diabetes, but they also have additional benefits in obesity management, cardiovascular risk reduction, and, to some extent, fatty liver disease
Written informed consent was obtained from all patients
Furthermore, in 2020, the American College of Cardiology (ACC) recommended their use in patients with T2DM who are at risk for ASCVD, heart failure, or kidney disease [74]
Serum 1,5-anhydroglucitol (GlycoMark): a short-term glycemic marker
